Results 141 to 150 of about 16,307,830 (290)

Anonymizing 1:M microdata with high utility. [PDF]

Knowl Based Syst, 2017
Gong Q, Luo J, Yang M, Ni W, Li XB.
europepmc   +1 more source

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

Molecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla, Christopher Dirks, Caroline Eiden, Sonja K. Fesenmayer, Femke M. Hormann, Yolande Klootsema, Ingrid Lilienthal, Si Min Zhang, Nikolas Herold, Sean G. Rudd   +9 more
wiley   +1 more source

Which guidelines from North America and Europe on cardiovascular risk management with statins have high utility in family medicine? [PDF]

Can Fam Physician
Supper I, François C, Hersart A, Meunier PY, Dibao-Dina C, Gueyffier F, Cauchon M, Boussageon R.   +7 more
europepmc   +1 more source

Mining of high utility-probability sequential patterns from uncertain databases. [PDF]

PLoS One, 2017
Zhang B, Lin JC, Fournier-Viger P, Li T.
europepmc   +1 more source

Differential expression of cancer‐related genes supports prediction of poor response to first‐line treatments in T‐ALL pediatric patients with high minimal residual disease

Molecular Oncology, EarlyView.
In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera, Laura Vela‐Martín, Pablo Fernández‐Navarro, José Luis López‐Lorenzo, Javier Cornago, Pilar Llamas, Eduardo Pérez‐Gómez, José Luis Marín‐Rubio, Manuel Fresno, Javier Santos, José Fernández‐Piqueras, María Villa‐Morales   +11 more
wiley   +1 more source

Aim high, stay private: differentially private synthetic data enables public release of behavioral health information with high utility. [PDF]

JAMIA Open
Ghasemizade M, Lovato J, Danforth C, Dodds PS, Bloomfield LSP, Price M, Near J.   +6 more
europepmc   +1 more source

Phytochemical and biotechnological studies on Schisandra chinensis cultivar Sadova No. 1-a high utility medicinal plant. [PDF]

Appl Microbiol Biotechnol, 2018
Szopa A, Klimek-Szczykutowicz M, Kokotkiewicz A, Maślanka A, Król A, Luczkiewicz M, Ekiert H.   +6 more
europepmc   +1 more source

Other title: House Bill 2682 - Testimony on Behalf of the Citizens' Utility Ratepayer Board by David Springe, Consumer Counsel

, 2008
application/pdf; "January 31, 2008."; Testimony before the Kansas Legislature, House Utilities Committee, presented by David Springe, Consumer Counsel, Citizens' Utility Ratepayer Board.Testimony in opposition to House Bill 2682.
Springe, David.
core  

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source

High utility of DNA barcoding for species identification and cryptic diversity in Korean aphids (Hemiptera: Aphididae). [PDF]

Sci Rep
Kang Y, Lee H, Park DK, Akimoto S, Hong KJ, Lee W.   +5 more
europepmc   +1 more source